Source comparison
PT-141 Versus PDE5 Inhibitors
The contrast here is fundamental and mechanistic. PDE5 inhibitors are peripheral vasodilators that facilitate the physical erectile response once desire and arousal are present; they do not create desire. Bremelanotide is a central agent that acts on the motiv
This comparison does not assign a generated winner or score.
- The contrast here is fundamental and mechanistic. PDE5 inhibitors are peripheral vasodilators that facilitate the physical erectile response once desire and arousal are present; they do not create desire. Bremelanotide is a central agent that acts on the motivation circuit itself, upstream of the vascular response. In practical research terms, they address different links in the chain: desire and arousal initiation for the melanocortin agonist, physical performance for the PDE5 inhibitor.
- Site of action
- Central (CNS, hypothalamus/limbic)
- Peripheral (penile vasculature)
- Primary mechanism
- MC4R agonism, dopaminergic modulation
- PDE5 inhibition, cGMP preservation
- Target of effect
- Sexual motivation and desire
- Physical erectile response
- Approved indication
- HSDD in premenopausal women
- Erectile dysfunction, PAH
- Key safety concern
- Transient BP rise, hyperpigmentation, nausea
- Hypotension, nitrate interaction